TABLE 2.
Survival of DH5α containing pSup-Test and a plasmid bearing wild-type MarR or putative superrepressor MarR mutant on gradient plates containing inducing compounds
Inducer | Concn (mM)a
|
||||||||
---|---|---|---|---|---|---|---|---|---|
pET11db | pmarOb | pSup-Testb | Wild-type MarR | MarR mutant
|
|||||
D26N | D26N/R27H | G95S | V132M | L135F | |||||
Plumbagin | >0.4 | >0.4 | ≤0.01 | 0.01 | 0.2 | 0.1 | 0.1 | 0.2 | 0.06 |
2,4-Dinitrophenol | >0.4 | >0.4 | 0.04 | 0.05 | 0.4 | 0.4 | 0.4 | 0.2 | 0.08 |
Sodium salicylate | >10 | >10 | ≤0.01 | 0.5 | 7.5 | 6.9 | 6.7 | 5.8 | 2.6 |
Sodium benzoate | >30 | >30 | 1.4 | 1.4 | 18.9 | 16.7 | 15.8 | 17.8 | 4.4 |
Menadione sodium metabisulfite | >5 | >5 | 1.6 | 2.8 | 3.5 | 3.6 | 3.5 | 3.1 | 2.7 |
Concentration of the inducer at which growth was inhibited in gradient plates. These values were calculated by measuring the point where growth stopped and dividing it by the total length (90 mm) of the gradient plate. This number was then multiplied by the highest concentration of inducer in the gradient plates, which were as follows: plumbagin, 0.4 mM; 2,4-dinitrophenol, 0.4 mM; sodium salicylate, 10 mM; sodium benzoate, 50 mM; menadione sodium metabisulfite, 5 mM. Results are representative of experiments performed in triplicate.
For details, see Table 1.